Literature DB >> 28667483

Is ellipsoid zone integrity essential for visual recovery in myopic neovascularization after anti-VEGF therapy?

Paolo Milani1, Marco Pellegrini2, Amedeo Massacesi3, Stefania Moschini3, Marco Setaccioli3, Davide Soranna4, Antonella Zambon4, Ferdinando Bottoni2, Fulvio Bergamini3.   

Abstract

PURPOSE: To evaluate functional prognostic factors and neuroretinal changes after anti-vascular endothelial growth factor (VEGF) treatment in patients with naïve, recent myopic neovascularization (mCNV), as assessed by spectral-domain optical coherence tomography (SD-OCT).
METHODS: Specific changes in tomographic features between baseline and final follow-up were retrospectively evaluated by two examiners independently. Imaging was obtained by a multi-modal imaging system which combines fluorescein angiography and SD-OCT.
RESULTS: Twenty-two eyes (male, six; female, 16; mean age, 65 ± 14 years) were considered. Mean follow-up was 21.5 ± 14 months. Best-corrected visual acuity (BCVA) improved from 0.38 ± 0.26 to 0.16 ± 0.20 logMAR (p < 0.001). The ellipsoid zone and the external limiting membrane (ELM) were disrupted in 21 (95.5%) and 15 (68.2%) eyes at baseline, and in 16 (72.7%) and nine (40.9%) eyes after therapy respectively. The ellipsoid zone and ELM were typically intact at lesion margins in 13 (59.1%) and 19 eyes (86.5%) respectively at baseline. The inner retina was intact in 20 eyes (91%). Six eyes (27.3%) exhibited complete regression without fibrosis. Absence of hemorrhage and integrity of lesion-adjacent ELM and of lesion-adjacent ellipsoid zone at baseline were factors for better final BCVA (p ≤ 0.05)
CONCLUSION: Vision gain might occur despite ellipsoid zone or ELM restoration. Hemorrhage could be considered a negative prognostic factor, integrity of lesion-adjacent ELM and of lesion-adjacent ellipsoid zone as positive prognostic factors. Myopic CNV can also resolve completely without fibrosis.

Entities:  

Keywords:  Anti-VEGF; Ellipsoid zone; External limiting membrane; Fluorescein angiography; Myopia; Myopic neovascularization; Neuroretina; Optical coherence tomography; Pathologic myopia; SD-OCT

Mesh:

Substances:

Year:  2017        PMID: 28667483     DOI: 10.1007/s00417-017-3706-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  25 in total

1.  Optical coherence tomography of choroidal neovascularization in high myopia.

Authors:  Takayuki Baba; Kyoko Ohno-Matsui; Takeshi Yoshida; Kenjiro Yasuzumi; Soh Futagami; Takashi Tokoro; Manabu Mochizuki
Journal:  Acta Ophthalmol Scand       Date:  2002-02

2.  Spectral-domain OCT in anti-VEGF treatment of myopic choroidal neovascularization.

Authors:  U Introini; G Casalino; G Querques; A T Gimeno; F Scotti; F Bandello
Journal:  Eye (Lond)       Date:  2012-04-27       Impact factor: 3.775

3.  Correlation Between Hyperreflective Foci and Clinical Outcomes in Neovascular Age-Related Macular Degeneration After Switching to Aflibercept.

Authors:  Kaveh Abri Aghdam; Amelie Pielen; Carsten Framme; Bernd Junker
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

4.  Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration.

Authors:  K Sayanagi; S Sharma; P K Kaiser
Journal:  Br J Ophthalmol       Date:  2009-02-10       Impact factor: 4.638

5.  Integrity of foveal photoreceptor layer in central retinal vein occlusion.

Authors:  Masafumi Ota; Akitaka Tsujikawa; Mihori Kita; Kazuaki Miyamoto; Atsushi Sakamoto; Noritatsu Yamaike; Yuriko Kotera; Nagahisa Yoshimura
Journal:  Retina       Date:  2008 Nov-Dec       Impact factor: 4.256

6.  Anti-VEGF therapy in myopic choroidal neovascularization: long-term results.

Authors:  Paulo Freitas-da-Costa; João Pinheiro-Costa; Beatriz Carvalho; Manuel Falcão; Elisete Brandão; Fernando Falcão-Reis; Ângela Carneiro
Journal:  Ophthalmologica       Date:  2014-05-16       Impact factor: 3.250

Review 7.  Anti-vascular endothelial growth factor for myopic choroidal neovascularization.

Authors:  Danny S Ng; Alvin K H Kwok; Clement W Chan
Journal:  Clin Exp Ophthalmol       Date:  2012 Jan-Feb       Impact factor: 4.207

8.  Imaging of naive myopic choroidal neovascularization by spectral-domain optical coherence tomography.

Authors:  Paolo Milani; Alfredo Pece; Luisa Pierro; Fulvio Bergamini
Journal:  Ophthalmologica       Date:  2014-04-16       Impact factor: 3.250

9.  Comparison of the optical coherence tomographic features of choroidal neovascular membranes in pathological myopia versus age-related macular degeneration, using quantitative subanalysis.

Authors:  P A Keane; S Liakopoulos; K T Chang; F M Heussen; S C Ongchin; A C Walsh; S R Sadda
Journal:  Br J Ophthalmol       Date:  2008-06-27       Impact factor: 4.638

Review 10.  Submacular hemorrhage in neovascular age-related macular degeneration: A synthesis of the literature.

Authors:  Dinu Stanescu-Segall; Florian Balta; Timothy L Jackson
Journal:  Surv Ophthalmol       Date:  2015-07-23       Impact factor: 6.048

View more
  7 in total

1.  Algorithm of the major and minor diagnostic criteria for active myopic choroidal neovascularization.

Authors:  Paolo Milani; Marco Mazzola; Mario Cigada; Amedeo Massacesi; Marco Setaccioli; Stefania Moschini; Stefano Ciaccia; Fabrizio Scotti; Elena Mantovani; Davide Soranna; Antonella Zambon; Fulvio Bergamini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-04-18       Impact factor: 3.535

2.  Outcome Predictors of SD-OCT-Driven Intravitreal Ranibizumab in Choroidal Neovascularization due to Myopia.

Authors:  Maria-Magdalena Guichard; Géraldine Peters; Cengiz Tuerksever; Christian Pruente; Katja Hatz
Journal:  Ophthalmologica       Date:  2019-08-06       Impact factor: 3.250

3.  Comment on: Diagnostic algorithm utilising multimodal imaging including optical coherence tomography angiography for the detection of myopic choroidal neovascularization.

Authors:  Paolo Milani; Fabrizio Scotti; Fulvio Bergamini
Journal:  Eye (Lond)       Date:  2020-02-06       Impact factor: 3.775

4.  ASSESSING THE ABILITY OF PREOPERATIVE QUANTITATIVE SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS TO PREDICT VISUAL OUTCOME IN IDIOPATHIC MACULAR HOLE SURGERY.

Authors:  Nitish Mehta; Fabio Lavinsky; Ryan Larochelle; Carl Rebhun; Nihaal B Mehta; Rebecca L Yanovsky; Michael N Cohen; Gregory D Lee; Vaidehi Dedania; Hiroshi Ishikawa; Gadi Wollstein; Joel S Schuman; Nadia Waheed; Yasha Modi
Journal:  Retina       Date:  2021-01-01       Impact factor: 3.975

5.  Baseline predictors for good visual gains after anti-vascular endothelial growth factor therapy for myopic choroidal neovascularization.

Authors:  Cherng-Ru Hsu; Tso-Ting Lai; Yi-Ting Hsieh; Tzyy-Chang Ho; Chung-May Yang; Chang-Hao Yang
Journal:  Sci Rep       Date:  2022-04-26       Impact factor: 4.996

6.  Factors associated with the recurrence of choroidal neovascularization in pathologic myopia.

Authors:  Ruixia Jing; Yuxia Bo; Lei Gao; Zhen Wang
Journal:  Front Med (Lausanne)       Date:  2022-09-12

7.  Long-Term Natural Outcomes of Simple Hemorrhage Associated with Lacquer Crack in High Myopia: A Risk Factor for Myopic CNV?

Authors:  Bing Liu; Xiongze Zhang; Lan Mi; Ling Chen; Feng Wen
Journal:  J Ophthalmol       Date:  2018-01-24       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.